$VRAX Up 148% Premarket! 🚀 🔹 Virax Biolabs is a diagnostics-focused biotech developing immune-profiling tools for post-viral syndromes, including Long COVID,

$VRAX Up 148% Premarket! 🚀 🔹 Virax Biolabs is a diagnostics-focused biotech developing immune-profiling tools for post-viral syndromes, including Long COVID, PTLD, and ME/CFS 🔹 Recent catalyst watch: completed UK recruitment for its ViraxImmune™ T-cell assay study with 160 participants 🧬 🔹 Comp…